In a study on pulmonary fibrosis (EMT), EPH was found to inhibit the EMT process and alleviate bleomycin‐induced lung fibrosis by blocking the NF‐κB signalling pathway and activating the Nrf‐2 signalling pathway [13]. The gene discussed is NFKB1; the disease is pulmonary fibrosis.